Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
$208M |
| 2 |
Norfolk Southern
NSC
|
$145M |
| 3 |
Insmed
INSM
|
$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$136M |
| 5 |
Soleno Therapeutics
SLNO
|
$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$355M |
| 2 |
Royalty Pharma
RPRX
|
$334M |
| 3 |
McDonald's
MCD
|
$198M |
| 4 |
Union Pacific
UNP
|
$188M |
| 5 |
HES
Hess
HES
|
$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Relay Therapeutics
RLAY
$710M
| – | – |
-1,400,000
| Closed | -$5.77M |
|
952
Roper Technologies
ROP
$55.8B
| – | – |
-116,813
| Closed | -$60.7M |
|
953
Rezolute
RZLT
$696M
| – | – |
-2,525,883
| Closed | -$12.4M |
|
954
Selective Insurance
SIGI
$4.86B
| – | – |
-10,000
| Closed | -$935K |
|
955
Amplify Junior Silver Miners ETF
SILJ
$2.07B
| – | – |
-75,000
| Closed | -$745K |
|
956
SL Green Realty
SLG
$4.4B
| – | – |
-35,000
| Closed | -$2.38M |
|
|
SLRN
957
DELISTED
ACELYRIN
SLRN
| – | – |
-450,000
| Closed | -$1.41M |
|
958
Snowflake
SNOW
$75.3B
| – | – |
-107,500
| Closed | -$16.6M |
|
959
Sarepta Therapeutics
SRPT
$1.96B
| – | – |
-175,000
| Closed | -$21.3M |
|
960
Sensata Technologies
ST
$4.66B
| – | – |
-582,538
| Closed | -$16M |
|
961
Seagate
STX
$40B
| – | – |
-94,101
| Closed | -$8.12M |
|
962
Savara
SVRA
$643M
| – | – |
-2,115,771
| Closed | -$6.5M |
|
963
Sysco
SYY
$39.4B
| – | – |
-133,224
| Closed | -$10.2M |
|
964
Protara Therapeutics
TARA
$122M
| – | – |
-2,250,000
| Closed | -$11.9M |
|
965
Teleflex
TFX
$5.78B
| – | – |
-3,405
| Closed | -$606K |
|
966
Timken Company
TKR
$5.42B
| – | – |
-240,664
| Closed | -$17.2M |
|
967
TPG
TPG
$8.64B
| – | – |
-65,000
| Closed | -$4.08M |
|
968
TransUnion
TRU
$17.5B
| – | – |
-90,000
| Closed | -$8.34M |
|
969
Taysha Gene Therapies
TSHA
$917M
| – | – |
-5,000,000
| Closed | -$8.65M |
|
970
Twilio
TWLO
$16.7B
| – | – |
-35,000
| Closed | -$3.78M |
|
971
Texas Roadhouse
TXRH
$11.2B
| – | – |
-66,407
| Closed | -$12M |
|
972
UGI
UGI
$7.43B
| – | – |
-425,000
| Closed | -$12M |
|
973
Vale
VALE
$44.4B
| – | – |
-450,000
| Closed | -$3.99M |
|
974
Vera Therapeutics
VERA
$1.54B
| – | – |
-480,000
| Closed | -$20.3M |
|
975
Vertiv
VRT
$47.4B
| – | – |
-136,474
| Closed | -$15.5M |
|